ST Jiuzhi: Announcement of Resolutions of the Fourth Meeting of the 9th Board of Directors
ST Jiuzhi: Progress Notice on Receiving the State Administration of Market Supervision and Administration\'s “Decision on Operators\' Centralized Anti-Monopoly Examination Not to Implement Further Examination” and proposed changes in control
ST Jiuzhi: Announcement of Resolutions of the First Meeting of the 9th Special Meeting of Independent Directors of the Board of Directors
ST Jiuzhi: Announcement on fiduciary voting rights and related transactions for wholly-owned subsidiaries
ST Jiuzhi: Announcement on the progress of share repurchases
ST Jiuzhi: Announcement on the adjustment of part of the main product hemostatic injection in the 2024 national medical insurance catalogue
ST Jiuzhi: Announcement on the cancellation of the share transfer agreement with Yifeng Pharmacy Chain Co., Ltd., by the majority shareholders of the company
ST Jiuzhi: Announcement on Abnormal Fluctuations in Stock Trading
ST Jiuzhi: SDIC Securities Co., Ltd.\'s financial advisory opinion on the detailed equity change report of Jiuzhitang Co., Ltd.
ST Jiuzhi: Detailed Equity Change Report of Jiuzhitang Co., Ltd. (Cheneng Venture Capital)
ST Jiuzhi: Proposed changes in shareholders\' agreement to transfer shares and control rights and changes in equity
ST Jiuzhi: Simplified Equity Change Report of Jiuzhitang Co., Ltd. (Li Zhenguo)
ST Jiuzhi: Announcement on the progress of share repurchases
ST Jiuzhi: Announcement on participating companies developing new drugs to launch clinical trials in China
ST Jiuzhi: 2024 Third Quarter Report
ST Jiuzhi: Announcement on the progress of share repurchases
ST Jiuzhi: Announcement on Abnormal Fluctuations in Stock Trading
ST Jiuzhi: Announcement on Participating in the 2024 Investor Online Group Reception Day Event in the Hunan Region
ST Jiuzhi: Legal Opinion of Hunan Qiyuan Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Jiuzhitang Co., Ltd.
ST Jiuzhi: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
No Data